Stocks extended Monday's sharp gains in hopes that next week's upcoming US reciprocal tariffs would be more targeted than previously stated and narrower than initially planned, with Mr. Trump saying, ...

Stock indexes are moderately higher today on carryover support from Monday's sharp gains in hopes that next week's upcoming US reciprocal tariffs would be more targeted than previously stated and ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Cambridge, USA-based clinical-stage oncology company Immuneering (Nasdaq: IMRX) announced the appointment of Dr Igor ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky joins as Immuneering plans to present updated data from Ph ...

Specifically, the company plans to present: Additional data from IMM-1-104 in combination with mGnP in first-line pancreatic cancer. Initial data from IMM-1-104 in combination with mFFX in first ...

It was meant to be a perfect reunion. Amelia Lofving, a designer, had just moved to Los Angeles. Her friend Jessica Brösche, a tattoo artist from Germany, was spending the winter in Mexico. The ...

1 Innate Cells and Th2 Immunity Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States 2 Department ...